Mysterious 2,500-Year-Old 'Gift to The Gods' Finally Identified
After several failed attempts over recent decades, researchers from the University of Oxford unraveled the strange substance's chemical degradation to reveal a sweet offering to an ancient Greek god 2,500 years ago; an appropriate gift, given honey is said to be what Zeus ate as a child.
Archeologist Luciana da Costa Carvalho and colleagues were able to detect a chemical fingerprint nearly identical to modern honey and beeswax using advanced gas chromatography and mass spectrometry techniques.
It was more acidic though, as would be expected from long-term storage where the sugars degrade into furans over time.
Related:
This also happens to beeswax, which was identified in one of the previous analyses, but the residue had a much more complicated composition to just be wax, the researchers argue.
While previous analyses were unable to detect any carbohydrates, the new analysis picked up the simple sugar hexose and the products of decomposed saccharides preserved in the corroded copper of the jar.
Excavated in 1954, the shrine at a Greek settlement in Paestum, Italy, was dedicated to an unknown deity. Inside, bronze jars surrounded an empty iron bed accompanied by six hydriai and two amphorae.
"The empty bed and the inaccessibility of the shrine signify that the deity was there," da Costa Carvalho and team describe in their paper, explaining honey is a "symbol of immortality".
Honey was also well known for its use as a sweetener and in medical preparations, cosmetics, and rituals in ancient Greece.
"Ancient residues aren't just traces of what people ate or offered to the gods – they are complex chemical ecosystems," says da Costa Carvalho. "Studying them reveals how those substances changed over time, opening the door to future work on ancient microbial activity and its possible applications."
This research was published in the Journal of the American Chemical Society.
Related News
4,000-Year-Old Handprint Discovered on Ancient Egyptian Artifact
Markings on Strange Stonehenge Boulder May Not Be Natural After All
Stomach-Churning Theory Could Explain Mystery of Neanderthal Diet
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 hours ago
- Yahoo
Sleepiness Could Be Triggered by a Power Overload in Our Brain
Denied of sleep, we find it but impossible to keep our eyes open and our thoughts focused. A new study based on fruit flies may have pin-pointed the origins of this biological lullaby, and with it a deeper understanding of our need for rest on a cellular level. Researchers from the University of Oxford in the UK have identified our cell's mitochondria as responsible for signaling when the body has to get some shut-eye as soon as possible. These tiny power generators cause a kind of metabolic overload in sleep-regulating neurons, the researchers suggest, which in simple terms indicates when our brain is running on empty. Through sleep, this overload can be reset, ensuring the brain remains in a healthy state. Related: "We set out to understand what sleep is for, and why we feel the need to sleep at all," says physiologist Gero Miesenböck. "Despite decades of research, no one had identified a clear physical trigger." "Our findings show that the answer may lie in the very process that fuels our bodies: aerobic metabolism." The team studied neurons responsible for regulating sleep in fruit flies, which have enough biological similarities to humans to make them useful for research. Through a comparison of well-rested and sleep-deprived fruit flies, the researchers identified differences in gene activity and electrical signaling. Overloaded mitochondria in sleep-deprived brains were found to shed electrons, increasing the generation of harmful waste products. The sleep-regulating neurons respond to these molecules by going into overdrive, making sleep a top biological priority. "You don't want your mitochondria to leak too many electrons," says neuroscientist Raffaele Sarnataro. "When they do, they generate reactive molecules that damage cells." Genetically engineering flies with a higher production of electrons in their sleep-regulating cells resulted in fruit flies that also slept more. Similarly, flies with a reduced level of electron generation slept less. There are, of course, other pressures on sleep, from how many coffees you have per day to the alignment of your circadian rhythm – the internal schedule that tells your body when it's time for bed. But now we have an actual cellular mechanism controlling sleep, and showing why we can't do without it. Anything new we learn about sleep can inform the treatment of sleep disorders and even neurological conditions such as Alzheimer's. These diseases are closely linked to sleep and the way it protects the brain, and connections to mitochondria could be something for future studies to investigate. The study also joins some of the dots between metabolism, sleep, and lifespan. Smaller animals tend to sleep more and live shorter lives, and the activity of mitochondria – and the waste that needs clearing up – could be part of the reason why. "This research answers one of biology's big mysteries," says Sarnataro. "Why do we need sleep? The answer appears to be written into the very way our cells convert oxygen into energy." The research has been published in Nature. Related News Study Reveals Key Way to Slow Chronic Illness in Old Age Liver Cancer Predicted to Double by 2050, But There Is Hope One Weekend Habit May Cut Risk of Heart-Related Death by 33%, Study Finds Solve the daily Crossword
Medscape
17 hours ago
- Medscape
Risankizumab Maintains Long-Term Effectiveness in Psoriasis
TOPLINE: Risankizumab was well tolerated and demonstrated sustained effectiveness and drug survival in patients with moderate-to-severe psoriasis over a period of 4 years. Obesity, difficult-to-treat sites, and prior biologic use delayed the response, whereas bio-naive patients had faster first-year outcomes. METHODOLOGY: Researchers conducted an observational retrospective study of patients with moderate-to-severe psoriasis, with or without psoriatic arthritis, at the Turin University Hospital between 2020 and 2024. A total of 545 adult participants (mean age at psoriasis onset, 33.3 years; 60.1% men) received risankizumab 150 mg at weeks 0 and 4 and then every 12 weeks subsequently. Study outcomes were the achievement of Psoriasis Area and Severity Index (PASI) 100 and PASI 90 at various timepoints between weeks 16 and 208. Drug survival, defined as the time from initiation to discontinuation, was evaluated alongside predictors of response to risankizumab including obesity, bio-naive status, and difficult-to-treat sites. TAKEAWAY: The mean PASI score decreased significantly from 14 at baseline to 0.4 at week 208. PASI 100 responses increased from 33% at week 16 to 74% at week 208, and PASI 90 responses increased from 47% to 85% over the same period. Bio-naive patients achieved PASI 100 more often than bio-experienced patients at week 16 (38% vs 27%; P = .025), week 28 (63% vs 44%; P < .001), and week 52 (73% vs 57%; P = .002); similar trends were seen for PASI 90. Similarly, patients without obesity were significantly more likely than those with obesity to achieve PASI 100 (66% vs 55%; P = .029) and PASI 90 (78% vs 63%; P = .012) at week 52. Drug survival was notably high at 87.2% for the observed cases after week 208. The presence of a difficult-to-treat site significantly reduced the risk for interruption (hazard ratio, 0.15; P < .001). Overall, 11.6% of patients discontinued the treatment, with the leading cause being secondary failure (38.1%), and adverse events prompted discontinuation in 13 patients. IN PRACTICE: "Risankizumab showed excellent effectiveness, safety, and DS [drug survival] over 4 years of treatment," the authors wrote. "Obesity and involvement of a difficult-to-treat area can lower the initial response, even if they did not affect treatment interruption," they concluded, observing that "bio-naïve patients benefit from a faster response during the first year of treatment." SOURCE: This study was led by Luca Mastorino, Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. It was published online on July 23, 2025, in Clinical and Experimental Dermatology. LIMITATIONS: The analysis of observed cases and those lost to follow-up weakened the 4-year survival estimate, showcasing an inherent limitation of real-world studies. Additionally, this study could not differentiate effectiveness on the basis of different difficult-to-treat sites. DISCLOSURES: This study did not receive any specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
21 hours ago
- Yahoo
Sticky goo in 2,500-year-old bronze jars finally identified, settling 70-year debate
When you buy through links on our articles, Future and its syndication partners may earn a commission. Globs of sticky goo discovered in the bottom of 2,500-year-old bronze jars from southern Italy have been chemically identified, settling a 70-year archaeological debate. It's honey — the sweet leftovers of an offering to an ancient god. A team of chemists and archaeologists used cutting-edge analysis techniques to test the paste-like residue. They concluded that the jars, which were found in the sixth-century-B.C. city of Paestum, originally contained honeycomb. "What I find interesting is that the ancient Greeks did think that honey was a superfood," study lead author Luciana da Costa Carvalho, a chemist at the University of Oxford, said in a video. The researchers published their findings Wednesday (July 30) in the Journal of the American Chemical Society. Honey and honeybees were important in ancient Greek and Roman medicine, rituals, cosmetics and food. So when archaeologists found eight bronze jars in an underground shrine in 1954, they assumed that the jars contained honey as a symbol of immortality. Despite at least four attempts over seven decades to confirm the presence of the sticky, sweet substance, no evidence of sugars was ever found. Related: Does honey ever go bad? But Carvalho and colleagues decided to take advantage of recent advances in chemical analysis techniques and to reopen the question of the gooey substance's origin. Using mass spectrometry, a technique that can identify different molecules and compounds, Carvalho and colleagues identified intact hexose sugars in the ancient jar residue for the first time. Fresh honey is about 79% hexose sugars, the researchers wrote in the study, with fructose being the most abundant. An analysis of the proteins in the ancient sample revealed the presence of royal jelly, a milky secretion made by worker bees. The researchers also recovered peptides — short amino acid chains that are smaller versions of proteins — unique to one species of honeybee: the European honeybee (Apis mellifera). Adding up these analyses, the researchers wrote that the study presents the first direct molecular evidence supporting the presence of honey, likely offered as honeycombs. "The amount of sugar in the ancient residue is very low compared to modern honey," Carvalho told Live Science in an email. "I think the residue tastes like washed honeycomb but slightly more acidic," Carvalho said, although she did not actually try it. The researchers also identified copper ions in the honey mixture. Because these ions are biocidal, meaning they can kill microorganisms, "their presence would have contributed to the preservations of sugars on the surface of the residue," Carvalho said, potentially explaining how the honey lasted thousands of years. The analysis of the goop can help archaeologists better understand ancient rituals and shrines. The jars were found in an underground shrine, also called a heroon, at Paestum. The heroon also included a large, wooden table with wool-wrapped iron rods placed on top. RELATED STORIES —Panathenaic prize amphora: A pot brimming with olive oil awarded at the ancient Greek Olympics —Depiction of Trojan War hero Ajax found in 1,800-year-old submerged building in Greece —Ancient Greeks may have built 'disability ramps' on some temples The offering may have been made to Is of Helice, the mythical founder of the ancient Greek city of Sybaris, located in what today is the arch of Italy's boot. When Sybaris was destroyed in the sixth century B.C., its inhabitants fled and founded a city called Poseidonia. But when the Romans took it over in the third century B.C., they renamed the city Paestum. The new study shows that "there is merit in reanalyzing museum collections because analytical techniques continue to develop," Carvalho said in the video. Solve the daily Crossword
